eLife assessment
This important study provides proof of the principle that C. elegans models can be used to accelerate the discovery of candidate treatments for human Mendelian diseases by detailed high-throughput phenotyping of strains harboring mutations in orthologs of human disease genes. The data presented are solid and would potentially be convincing if complete data sets were to be made available to the scientific community. This approach enables the potential rapid repurposing of FDA-approved drugs to treat rare diseases for which there are currently no effective treatments.